DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Verismo Therapeutics, Inc.
Verismo Therapeutics, Inc.
Stage unknownPhiladelphia, PAOther Health Care
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
1 rounds
- Apr 21, 2026Form D equity offering · $28.0M (form d sold) · 1 investorsFact SEC EDGAR Form D data sets (quarterly) · “Verismo Therapeutics, Inc. filed Form D: $28,000,000 sold of $28,000,000, Other Health Care”
Investors on record
0 edges
No named investor yet.
People
2 officers, 3 directors
- Bryan B. Kim Executive Officer/Director sec.gov
- Gene Kim Executive Officer sec.gov
- Jong Sun Yoon Director Fact
- Dong Gun Kim Director Fact
- Yang Gon Jin Director Fact
Timeline
1
- May 20, 2026Verismo Therapeutics, Inc. filed Form D: $28,000,000 sold of $28,000,000, Other Health CareForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
14 observations
Every observation on this company
- Entity type: Corporation May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Other Health Care May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $28.0M May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $28.0M May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2026-04-21 May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 1 May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 3675 Market Street, Suite 200, Philadelphia, PA, 19104 May 20, 2026 Fact SEC EDGAR Form D data sets (quarterly)